N 6022 is primarily utilized in research settings as a potent and selective inhibitor of S-nitrosoglutathione reductase (GSNOR). This enzyme plays a critical role in regulating cellular levels of S-nitrosothiols, which are important signaling molecules involved in various physiological processes, including cardiovascular function and immune response. By inhibiting GSNOR, N 6022 helps researchers study the impact of S-nitrosothiol modulation in diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). Its application extends to exploring potential therapeutic strategies for conditions where nitric oxide signaling is dysregulated, offering insights into novel treatment approaches.